TNNI3 and COVID-19: Another clinical study with 187 COVID-19 patients showed that 35% of them had comorbidities like hypertension, cardiomyopathy and 28% exhibited acute myocardial injury which was characterized by high levels of cardiac troponin I (cTnI) [158].